You are here

Article info

Article menu

Download PDFPDF

Sjögren syndrome
Original article
Type I IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in utero

Authors

  • Malin Hedlund Rheumatology Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Gudny Ella Thorlacius Rheumatology Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Margarita Ivanchenko Rheumatology Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Vijole Ottosson Rheumatology Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Nikolaos Kyriakidis Rheumatology Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden Facultad de Ciencias de la Salud, Escuela de Medicina, Grupo de Investigación en Biotecnología Aplicada a Biomedicina (BIOMED), Universidad de Las Américas (UDLA), Quito, Ecuador PubMed articlesGoogle scholar articles
  • Linda Lagnefeldt Pediatric Cardiology Unit, Department of Women's and Children's Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Joanna Tingström Rheumatology Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Allan Sirsjö Cardiovascular Research Centre, School of Health and Medical Sciences, Örebro Univeristy, Örebro, Sweden PubMed articlesGoogle scholar articles
  • Anders A Bengtsson Division of Rheumatology, Department of Clinical Sciences, Lund University, Lund, Sweden PubMed articlesGoogle scholar articles
  • Emma Aronsson Division of Obstetrics and Gynecology, Department of Women's and Children's Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Kristina Gemzell-Danielsson Division of Obstetrics and Gynecology, Department of Women's and Children's Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Lars Ronnblom Rheumatology, Department of Medical Sciences, Science for Life Laboratory, Uppsala University, Uppsala, Sweden PubMed articlesGoogle scholar articles
  • Gunnar Bergman Pediatric Cardiology Unit, Department of Women's and Children's Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Alexander Espinosa Rheumatology Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Sven-Erik Sonesson Pediatric Cardiology Unit, Department of Women's and Children's Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Maija-Leena Eloranta Rheumatology, Department of Medical Sciences, Science for Life Laboratory, Uppsala University, Uppsala, Sweden PubMed articlesGoogle scholar articles
  • Marie Wahren-Herlenius Rheumatology Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Marie Wahren-Herlenius; marie.wahren{at}ki.se
View Full Text

Citation

Hedlund M, Thorlacius GE, Ivanchenko M, et al
Type I IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in utero
RMD Open 2020;6:e000989. doi: 10.1136/rmdopen-2019-000989

Publication history

  • Received April 25, 2019
  • Revision received November 8, 2019
  • Accepted November 17, 2019
  • First published January 7, 2020.
Online issue publication 
May 29, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.